Table 2. Binding Affinities of OP-NT Hybrids and Reference Peptides to the Human Opioid and NT Receptors.
affinity Ki (nM)a |
||||||
---|---|---|---|---|---|---|
peptide | MOR | DOR | KOR | NTS1 | NTS2 | selectivity NTS2/NTS1 |
KGOP01b | 0.14 ± 0.06 | 1.51 ± 0.26 | 16.6 ± 5.7 | N/Ad | N/Ad | N/Ad |
NT(8-13)c | N/Ad | N/Ad | N/Ad | 0.90 ± 0.03 | 0.55 ± 0.2 | 1.6 |
PK20 | 4.13 ± 1.4 | 46.4 ± 3.6 | 33.5 ± 6.2 | 188 ± 29 | 29.5 ± 11 | 6.4 |
1c | N/Ad | N/Ad | N/Ad | 3.6 ± 0.4 | 0.46 ± 0.03 | 7.8 |
2c | N/Ad | N/Ad | N/Ad | 3790 ± 1300 | 2.86 ± 1.3 | 1324 |
3 | 1.32 ± 0.45 | 56.4 ± 4.5 | 78.6 ± 20 | 0.43 ± 0.07 | 0.09 ± 0.07 | 4.8 |
4 | 4.89 ± 0.30 | 213 ± 44 | 201 ± 80 | 2.3 ± 0.4 | 0.29 ± 0.2 | 7.7 |
5 | 1.11 ± 0.39 | 159 ± 94 | 102 ± 8.0 | 0.78 ± 0.2 | 0.03 ± 0.03 | 27 |
6 | 7.15 ± 0.83 | 276 ± 42 | 138 ± 16 | 13 ± 1.3 | 0.16 ± 0.05 | 81 |
7 | 1.75 ± 0.43 | 101 ± 2.0 | 27.9 ± 4.1 | 4.0 ± 0.05 | 0.003 ± 0.001 | 1333 |
8 | 7.12 ± 2.0 | 48.6 ± 5.7 | 208 ± 76 | 15 ± 2 | 0.32 ± 0.5 | 50 |
9 | 1.67 ± 0.16 | 105 ± 35 | 22.4 ± 1.6 | 4710 ± 580 | 1.72 ± 4.0 | 2739 |
10 | 6.24 ± 0.48 | 209 ± 25 | 150 ± 53 | 6830 ± 4000 | 75.0 ± 80 | 91 |
11 | 1.73 ± 0.62 | 60.9 ± 8.6 | 19.9 ± 4.2 | 12.4 ± 0.9 | 0.33 ± 0.04 | 33 |
12 | 3.99 ± 0.97 | 200 ± 73 | 70.9 ± 15 | 59 ± 1.5 | 0.50 ± 0.45 | 118 |
13c | N/Ad | N/Ad | N/Ad | 2.3 ± 0.2 | 0.11 ± 0.07 | 20.1 |
14c | N/Ad | N/Ad | N/Ad | 13.4 ± 2.0 | 3.0 ± 2.0 | 4.5 |
15c | N/Ad | N/Ad | N/Ad | 6680 ± 3700 | 132 ± 47 | 50 |
16c | N/Ad | N/Ad | N/Ad | 93.0 ± 22 | 24.0 ± 18 | 4 |
Determined in competitive radioligand binding assays using membranes from CHO cells (opioid and NTS1 receptors) or 1321N1 astrocytoma cells (NTS2 receptors) stably expressing the human receptors. Ki values are reported as the means ± SEM of three independent experiments performed in duplicate (binding to the opioid receptors) or triplicate (binding to the NT receptors).
Data taken from ref (25).
Data taken from ref (11).
N/A, not applicable.